Fatigue, a common complaint in clinical practice, often presents a diagnostic challenge due to its multifactorial etiology. Understanding the complex nature of fatigue is crucial for healthcare professionals to effectively manage and treat this condition.
Fatigue is a subjective feeling of tiredness, weariness, or lack of energy. It can be categorized into physical and mental fatigue. Physical fatigue refers to the inability to continue functioning at the level of one's normal abilities. Mental fatigue, on the other hand, is characterized by a decrease in sustained attention and cognitive function.
Fatigue is a symptom, not a disease, and can be a sign of several medical conditions. It involves interactions between peripheral and central nervous system processes. The exact pathophysiology is not fully understood, but it is thought that inflammatory cytokines, hormonal imbalances, metabolic disorders, and psychosocial factors play a role.
Evaluating a patient with fatigue requires a comprehensive approach. A detailed history and physical examination are essential to identify potential causes. Investigations may include complete blood count, thyroid function tests, serum electrolytes, liver and kidney function tests, and inflammatory markers. Depending on the initial findings, more specific tests may be needed.
Management strategies should be individualized based on the underlying cause. This may involve pharmacological treatment, lifestyle modifications, or referral to specialist services. Cognitive-behavioral therapy and graded exercise therapy have shown promise in managing chronic fatigue syndrome.
Fatigue is a complex symptom with a broad differential diagnosis. A comprehensive clinical approach is essential for its effective management. Further research is needed to fully understand the pathophysiology of fatigue and develop more effective treatment strategies.
1.
Stem Cell Selection Unneeded for SSc Transplant Therapy?
2.
Radiation from CT scans could account for 5% of all cancer cases a year, study suggests
3.
Do I have prostate cancer? Why a simple PSA blood test alone won't give you the answer
4.
In Hemophilia A and B, a Novel Monoclonal Antibody Reduces Bleeding.
5.
Tumor infiltration of major blood vessels, not metastasis, may be primary cause of cancer death
1.
Revolutionizing Oncology Trials: Optimization, Matching, Diversity, and Decentralization
2.
Emerging Dysregulated Signaling Pathways in Early-Onset Colorectal Cancer
3.
Exploring the Use of Bevacizumab in Treating Different Types of Cancers
4.
A Closer Look at Poorly Differentiated Carcinoma: Uncovering its Complexities
5.
Unlocking the Secrets of Squamous Cell Carcinoma: New Hope for Patients
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients
2.
The Era of Targeted Therapies for ALK+ NSCLC: A Paradigm Shift
3.
A New Era in Managing Cancer-Associated Thrombosis
4.
Navigating the Complexities of Ph Negative ALL - Part IX
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VIII
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation